Oligomerizer) is designed to detect cells that have been virally infected and then eradicate only the infected cells, rapidly ending the infection. DRACO has proven effective in vivo against influenza and three hemorrhagic fever viruses, and in vitro against 15 different viruses – including common cold viruses, the H1N1 influenza strain, adenoviruses, a mouse polio virus, dengue fever, and stomach viruses, among others. It has also been tested and proven safe in both mice and 11 different human and animal cell types representing organs like the heart, lungs, liver, and kidney, among others.
DRACO is designed to be attracted to a specific type of RNA exclusive to viral infections – long double-stranded RNA, or dsRNA. Detecting this dsRNA in a human or animal cell indicates that that host cell has been taken over by a virus and is now in the process of creating more viruses. DRACO enters cells and attaches itself to any dsRNA. Once two or more DRACOs attach to the dsRNA, they interact with one another and activate a natural self-destruct switch inside the infected cell, terminating the infected cell and the virus that it was helping to reproduce.
DRACO is designed to be both broad-spectrum and nontoxic to humans – overcoming existing issues with current anti-viral treatments. Because DRACO is so broad-spectrum and acts so rapidly, there is little opportunity for the virus to evolve defenses against this treatment, Rider said.
Rider is expanding his DRACO research and testing more strains of various viruses in cells and animals.
DRACO has been funded by grant AI057159 from the National Institute of Allergy and Infectious Diseases and the New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases, with other funding coming from DARPA, the Defense Threat Reduction Agency, and the office of the Director of Defense Research and Engineering.
Draper Laboratory, which celebra
Page: 1 2 3 4 Related biology technology :1
Copyright©2012 Vocus, Inc.
All rights reserved
. Draper Mobile Technology Could Aid War on Obesity2
. Health Officials Could Identify & Act on Crises Earlier With New Draper Biosurveillance Tool3
. Draper/MIT Space Suits Could Enable Asteroid Exploration, Satellite Repairs4
. Draper Device Could Help Pave Way Towards “Kidney-On-A-Chip” Development5
. Nanotechnology experts to gather in Singapore for 3rd Nano Today Conference6
. ‘Wonder of Nanotechnology’ Details Research Enabling Nanoscale Optoelectronic Devices7
. “Outlook” with “Ben Kingsley” Features Programming Discussing the Role of Nanotechnology in Medicine8
. Will Safety Concerns Slow Nanotechnology Drug Delivery Market Growth? Forecasts Predict 84.79% Growth in US, 73.97% Globally through 20169
. Regenerative Medicine Company, Eqalix, Announces Grant from Nanotechnology Institute in Philadelphia, Pennsylvania10
. Lockheed Martin and Nanyang Technological University to collaborate on nanotechnology11
. Notre Dame study explores the potential benefits and threats of nanotechnology research